Inhibition of Candida albicans biofilm formation and modulation of gene expression by probiotic cells and supernatant

Journal of Medical Microbiology

Volumn 65, Issue 4, 2016, Pages 328-336

  James, K M ^a,b   MacDonald, K W ^b   Chanyi, R M ^a,b   Cadieux, P A ^a,b,c   Burton, J P ^b,c  

^a Fanshawe College   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c LAWSON HEALTH RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADHESIN; FUNGAL PROTEIN; HYPHAL WALL PROTEIN1; INVASIN; PROBIOTIC AGENT; PROTEINASE; SAP5 PROTEIN; UNCLASSIFIED DRUG; TRANSCRIPTION FACTOR;

ARTICLE; BIOFILM; CANDIDA ALBICANS; CONTROLLED STUDY; FUNGAL GENE; FUNGUS HYPHAE; GENE EXPRESSION; LACTOBACILLUS HELVETICUS; LACTOBACILLUS PLANTARUM; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; STREPTOCOCCUS SALIVARIUS; SUPERNATANT; EPITHELIUM CELL; GENE EXPRESSION REGULATION; GENETICS; GROWTH, DEVELOPMENT AND AGING; HUMAN; PHYSIOLOGY;

BIOFILMS; CANDIDA ALBICANS; EPITHELIAL CELLS; FUNGAL PROTEINS; GENE EXPRESSION REGULATION, FUNGAL; HUMANS; HYPHAE; LACTOBACILLUS HELVETICUS; LACTOBACILLUS PLANTARUM; PROBIOTICS; REAL-TIME POLYMERASE CHAIN REACTION; STREPTOCOCCUS SALIVARIUS; TRANSCRIPTION FACTORS;

EID: 84962016431     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.000226     Document Type: Article

References (53)

1. Abe, S., Satoh, T., Tokuda, Y., Tansho, S. & Yamaguchi, H. (1994). A rapid colorimetric assay for determination of leukocyte-mediated inhibition of mycelial growth of Candida albicans. Microbiol Immunol 38, 385–388.
2. Andes, D. (2003). In vivo pharmacodynamics of antifungal drugs in treatment of candidiasis. Antimicrob Agents Chemother 47, 1179–1186.
3. Baillie, G. S. & Douglas, L. J. (1999). Role of dimorphism in the development of Candida albicans biofilms. J Med Microbiol 48, 671–679.
4. Bal, A. M. (2010). The echinocandins: three useful choices or three too many? Int J Antimicrob Agents 35, 13–18.
5. Burton, J. P., Drummond, B. K., Chilcott, C. N., Tagg, J. R., Thomson, W. M., Hale, J. D. F. & Wescombe, P. A. (2013). Influence of the probiotic Streptococcus salivarius strain M18 on indices of dental health in children: a randomized double-blind, placebo-controlled trial. J Med Microbiol 62, 875–884.
6. Campisi, G., Panzarella, V., Matranga, D., Calvino, F., Pizzo, G., Lo Muzio, L. & Porter, S. (2008). Risk factors of oral candidosis: a twofold approach of study by fuzzy logic and traditional statistic. Arch Oral Biol 53, 388–397.
7. Cotter, G. & Kavanagh, K. (2000). Adherence mechanisms of Candida albicans. Br J Biomed Sci 57, 241–249.
8. Drago, L., Mombelli, B., De Vecchi, E., Bonaccorso, C., Fassina, M. C. & Gismondo, M. R. (2000). Candida albicans cellular internalization: a new pathogenic factor? Int J Antimicrob Agents 16, 545–547.
9. Egusa, H., Soysa, N. S., Ellepola, A. N., Yatani, H. & Samaranayake, L. P. (2008). Oral candidosis in HIV-infected patients. Curr HIV Res 6, 485–499.
10. Fukushima, C., Matsuse, H., Saeki, S., Kawano, T., Machida, I., Kondo, Y. & Kohno, S. (2005). Salivary IgA and oral candidiasis in asthmatic patients treated with inhaled corticosteroid. J Asthma 42, 601–604.
11. Gow, N. A. R., van de Veerdonk, F. L., Brown, A. J. P. & Netea, M. G. (2012). Candida albicans morphogenesis and host defence: discriminating invasion from colonization. Nat Rev Microbiol 10, 112–122.
12. Gropp, K., Schild, L., Schindler, S., Hube, B., Zipfel, P. F. & Skerka, C. (2009). The yeast Candida albicans evades human complement attack by secretion of aspartic proteases. Mol Immunol 47, 465–475.
13. Harriott, M. M. & Noverr, M. C. (2011). Importance of Candidabacterial polymicrobial biofilms in disease. Trends Microbiol 19, 557–563.
14. Hatakka, K., Ahola, A. J., Yli-Knuuttila, H., Richardson, M., Poussa, T., Meurman, J. H. & Korpela, R. (2007). Probiotics reduce the prevalence of oral candida in the elderly - a randomized controlled trial. J Dent Res 86, 125–130.
15. Herzberg, M. C., Meyer, M. W., Kilic, A. & Tao, L. (1997). Hostpathogen interactions in bacterial endocarditis: streptococcal virulence in the host. Adv Dent Res 11, 69–74.
16. Hoyer, L. L. (2001). The ALS gene family of Candida albicans. Trends Microbiol 9, 176–180.
17. Ishijima, S. A., Hayama, K., Burton, J. P., Reid, G., Okada, M., Matsushita, Y. & Abe, S. (2012). Effect of Streptococcus salivarius K12 on the in vitro growth of Candida albicans and its protective effect in an oral candidiasis model. Appl Environ Microbiol 78, 2190–2199.
18. Jenkinson, H. F., Lala, H. C. & Shepherd, M. G. (1990). Coaggregation of Streptococcus sanguis and other streptococci with Candida albicans. Infect Immun 58, 1429–1436.
19. Jiang, Q., Stamatova, I., Kari, K. & Meurman, J. H. (2015). Inhibitory activity in vitro of probiotic lactobacilli against oral Candida under different fermentation conditions. Benef Microbes 6, 361–368.
20. Kamagata-Kiyoura, Y., Abe, S., Yamaguchi, H. & Nitta, T. (2003). Detachment activity of human saliva in vitro for Candida albicans cells attached to a plastic plate. J Infect Chemother 9, 215–220.
21. Li, F. & Palecek, S. P. (2003). EAP1, a Candida albicans gene involved in binding human epithelial cells. Eukaryot Cell 2, 1266–1273.
22. Liu, Y. & Filler, S. G. (2011). Candida albicans Als3, a multifunctional adhesin and invasin. Eukaryot Cell 10, 168–173.
23. Lo, H. J., Köhler, J. R., DiDomenico, B., Loebenberg, D., Cacciapuoti, A. & Fink, G. R. (1997). Nonfilamentous C. albicans mutants are avirulent. Cell 90, 939–949.
24. Mendonça, F. H., Santos, S. S., Faria, I. S., Gonçalves e Silva, R., Jorge, A. O. & Leão, M. V. (2012). Effects of probiotic bacteria on Candida presence and IgA anti-Candida in the oral cavity of elderly. Braz Dent J 23, 534–538.
25. Naglik, J. R., Challacombe, S. J. & Hube, B. (2003). Candida albicans secreted aspartyl proteinases in virulence and pathogenesis. Microbiol Mol Biol Rev 67, 400–428.
26. Nett, J. E., Sanchez, H., Cain, M. T. & Andes, D. R. (2010). Genetic basis of Candida biofilm resistance due to drug-sequestering matrix glucan. J Infect Dis 202, 171–175.
27. Nobile, C. J., Nett, J. E., Andes, D. R. & Mitchell, A. P. (2006). Function of Candida albicans adhesin Hwp1 in biofilm formation. Eukaryot Cell 5, 1604–1610.
28. Paturi, G., Phillips, M. & Kailasapathy, K. (2008). Effect of probiotic strains Lactobacillus acidophilus LAFTI L10 and Lactobacillus paracasei LAFTI L26 on systemic immune functions and bacterial translocation in mice. J Food Prot 71, 796–801.
29. Phan, Q. T., Myers, C. L., Fu, Y., Sheppard, D. C., Yeaman, M. R., Welch, W. H., Ibrahim, A. S., Edwards, J. E., Jr. & Filler, S. G. (2007). Als3 is a Candida albicans invasin that binds to cadherins and induces endocytosis by host cells. PLoS Biol 5, e64.
30. Radfar, L., Shea, Y., Fischer, S.H., Sankar, V., Leakan, R. A., Baum, B. J. & Pillemer, S. R. (2003). Fungal load and candidiasis in Sjögren’s syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 96, 283–287.
31. Rajendran, R., Robertson, D. P., Hodge, P. J., Lappin, D. F. & Ramage, G. (2010). Hydrolytic enzyme production is associated with Candida albicans biofilm formation from patients with type 1 diabetes. Mycopathologia 170, 229–235.
32. Ramage, G., VandeWalle, K., Lò pez-Ribot, J. L. & Wickes, B. L. (2002). The filamentation pathway controlled by the Efg1 regulator protein is required for normal biofilm formation and development in Candida albicans. FEMS Microbiol Lett 214, 95–100.
33. Ramage, G., Martĺnez, J. P. & Lò pez-Ribot, J. L. (2006). Candida biofilms on implanted biomaterials: a clinically significant problem. FEMS Yeast Res 6, 979–986.
34. Reinholdt, J., Krogh, P. & Holmstrup, P. (1987). Degradation of IgA1, IgA2, and S-IgA by Candida and Torulopsis species. Acta Pathol Microbiol Immunol Scand C 95, 265–274.
35. Rüchel, R. (1986). Cleavage of immunoglobulins by pathogenic yeasts of the genus Candida. Microbiol Sci 3, 316–319.
36. Sardi, J. C., Duque, C., Mariano, F. S., Peixoto, I. T., Höfling, J. F. & Gonçalves, R. B. (2010). Candida spp. in periodontal disease: a brief review. J Oral Sci 52, 177–185.
37. Schauer, F. & Hanschke, R. (1999). [Taxonomy and ecology of the genus Candida]. Mycoses 42 (1), 12–21 (in German).
38. Shapiro, R. S., Robbins, N. & Cowen, L. E. (2011). Regulatory circuitry governing fungal development, drug resistance, and disease. Microbiol Mol Biol Rev 75, 213–267.
39. Silverman, R. J., Nobbs, A. H., Vickerman, M. M., Barbour, M. E. & Jenkinson, H. F. (2010). Interaction of Candida albicans cell wall Als3 protein with Streptococcus gordonii SspB adhesin promotes development of mixed-species communities. Infect Immun 78, 4644–4652.
40. Soysa, N. S., Samaranayake, L. P. & Ellepola, A. N. (2008). Antimicrobials as a contributory factor in oral candidosis - a brief overview. Oral Dis 14, 138–143.
41. Staab, J. F., Bradway, S. D., Fidel, P. L. & Sundstrom, P. (1999). Adhesive and mammalian transglutaminase substrate properties of Candida albicans Hwp1. Science 283, 1535–1538.
42. Staib, P., Kretschmar, M., Nichterlein, T., Hof, H. & Morschhäuser, J. (2002). Transcriptional regulators Cph1p and Efg1p mediate activation of the Candida albicans virulence gene SAP5 during infection. Infect Immun 70, 921–927.
43. Sudbery, P. E. (2011). Growth of Candida albicans hyphae. Nat Rev Microbiol 9, 737–748.
44. Sudbery, P., Gow, N. & Berman, J. (2004). The distinct morphogenic states of Candida albicans. Trends Microbiol 12, 317–324.
45. Theberge, S., Semlali, A., Alamri, A., Leung, K. P. & Rouabhia, M. (2013). Calbicans growth, transition, biofilm formation, and gene expression modulation by antimicrobial decapeptide KSL-W. BMC Microbiol 13, 246–260.
46. Thompson, G. R., Patel, P. K., Kirkpatrick, W. R., Westbrook, S. D., Berg, D., Erlandsen, J., Redding, S. W. & Patterson, T. F. (2010). Oropharyngeal candidiasis in the era of antiretroviral therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 109, 488–495.
47. Ujaoney, S., Chandra, J., Faddoul, F., Chane, M., Wang, J., Taifour, L., Mamtani, M. R., Thakre, T. P., Kulkarni, H. & other authors (2014). In vitro effect of over-the-counter probiotics on the ability of Candida albicans to form biofilm on denture strips. J Dent Hyg 88, 183–189.
48. Uppuluri, P., Pierce, C. G., Thomas, D. P., Bubeck, S. S., Saville, S. P. & Lo´ pez-Ribot, J. L. (2010). The transcriptional regulator Nrg1p controls Candida albicans biofilm formation and dispersion. Eukaryot Cell 9, 1531–1537.
49. Vazquez, J. A. (2010). Invasive fungal infections in the intensive care unit. Semin Respir Crit Care Med 31, 79–86.
50. Weerasuriya, N. & Snape, J. (2008). Oesophageal candidiasis in elderly patients: risk factors, prevention and management. Drugs Aging 25, 119–130.
51. Williams, D. & Lewis, M. (2011). Pathogenesis and treatment of oral candidosis. J Oral Microbiol 3, 1–11.
52. Wu, H., Downs, D., Ghosh, K., Ghosh, A. K., Staib, P., Monod, M. & Tang, J. (2013). Candida albicans secreted aspartic proteases 4-6 induce apoptosis of epithelial cells by a novel Trojan horse mechanism. FASEB J 27, 2132–2144.
53. Zomorodian, K., Haghighi, N. N., Rajaee, N., Pakshir, K., Tarazooie, B., Vojdani, M., Sedaghat, F. & Vosoghi, M. (2011). Assessment of Candida species colonization and denture-related stomatitis in complete denture wearers. Med Mycol 49, 208–211.